You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 3, March 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE NINTH ANNUAL SURGICAL SYMPOSIUM OF THE ASSOCIATION OF VETERANS ADMINISTRATION SURGEONS, TAMPA, FLA, MAY 8-11, 1985
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Serum Kinetics of Intraperitoneal Moxalactam

Donald E. Fry, MD; Laura Trachtenberg, MS; Hiram C. Polk, Jr, MD

Arch Surg. 1986;121(3):282-284.


Abstract

• Continuous intraperitoneal administration of antibiotics has been recommended as treatment for peritonitis. The necessity of simultaneous systemic administration of antibiotics remains undefined but usually is performed. Moxalactam kinetics in serum were studied in dogs receiving (1) 15 mg/kg intravenously; (2) 15 mg/kg intraperitoneally; (3) 5 mg/kg hourly with peritoneal lavage; (4) 15 mg/kg intravenously followed by 5 mg/kg hourly intraperitoneally; (5) 15 mg/kg intraperitoneally after 24 hours of peritonitis; and (6) 5 mg/kg hourly by peritoneal lavage after 24 hours of peritonitis. intraperitoneally administered moxalactam resulted in sustained serum levels compared with intravenously administered drugs. Repeated exchanges in lavage fluid resulted in progressively higher serum levels with each exchange. Peritonitis results in statistically higher levels of serum antibiotic concentration when compared with controls. Continuous intraperitoneal lavage with antibiotics would not appear to require concomitant systemic drug therapy.

(Arch Surg 1986;121:282-284)



Author Affiliations

From the Departments of Surgery, University of Louisville School of Medicine (Dr Polk and Ms Trachtenberg) and Case Western Reserve University School of Medicine (Dr Fry), Cleveland; the Price Institute of Surgical Research, Louisville; and the Surgical Service, Veterans Administration Medical Center, Cleveland (Dr Fry).


Footnotes

Accepted for publication Sept 26, 1985.

Read before the Ninth Annual Surgical Symposium of the Association of Veterans Administration Surgeons, Tampa, Fla, May 11, 1985.

Reprint requests to Surgical Service (112), VA Medical Center, 10701 East Blvd, Cleveland, OH 44106 (Dr Fry).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.